Skip to main content

NIKTIMVO

NDC 50881-023 · Incyte Corporation

Generic nameaxatilimab-csfr

Dosage formINJECTION

RouteINTRAVENOUS

Active ingredient(s)AXATILIMAB

Strength22 mg/.44mL

Pharmacologic classColony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA], Colony Stimulating Factor-1 Receptor Blocker [EPC]

Marketing categoryBLA

Packages

50881-023-11 — 1 VIAL, SINGLE-USE in 1 CARTON (50881-023-11) / .44 mL in 1 VIAL, SINGLE-USE

Billed under HCPCS

J9038 — Injection, axatilimab-csfr, 0.1 mg Medicare Part B payment limit (ASP + 6%): $56.46

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50881-012 — axatilimab-csfr, 50881-034 — axatilimab-csfr, 50881-036 — axatilimab-csfr, 50881-047 — axatilimab-csfr

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels